These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34768455)

  • 1. The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies.
    Maraolo AE; Crispo A; Piezzo M; Di Gennaro P; Vitale MG; Mallardo D; Ametrano L; Celentano E; Cuomo A; Ascierto PA; Cascella M
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial and harmful outcomes of tocilizumab in severe COVID-19: A systematic review and meta-analysis.
    Rubio-Rivas M; Forero CG; Mora-Luján JM; Montero A; Formiga F; Homs NA; Albà-Albalate J; Sánchez L; Rello J; Corbella X
    Pharmacotherapy; 2021 Nov; 41(11):884-906. PubMed ID: 34558742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis.
    Boregowda U; Perisetti A; Nanjappa A; Gajendran M; Kutti Sridharan G; Goyal H
    Front Med (Lausanne); 2020; 7():586221. PubMed ID: 33123544
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis.
    Conti V; Corbi G; Sellitto C; Sabbatino F; Maci C; Bertini N; De Bellis E; Iuliano A; Davinelli S; Pagliano P; Filippelli A
    J Pers Med; 2021 Jul; 11(7):. PubMed ID: 34357095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased Mortality in Coronavirus Disease 2019 Patients Treated With Tocilizumab: A Rapid Systematic Review and Meta-analysis of Observational Studies.
    Malgie J; Schoones JW; Pijls BG
    Clin Infect Dis; 2021 Jun; 72(11):e742-e749. PubMed ID: 32964913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocilizumab for COVID-19: A systematic review and meta-analysis of randomized controlled trials.
    Boppana TK; Mittal S; Madan K; Mohan A; Hadda V; Guleria R
    Monaldi Arch Chest Dis; 2022 Feb; 92(4):. PubMed ID: 35130679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocilizumab as treatment for COVID-19: A systematic review and meta-analysis.
    Petrelli F; Cherri S; Ghidini M; Perego G; Ghidini A; Zaniboni A
    World J Methodol; 2021 May; 11(3):95-109. PubMed ID: 34026583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    Juul S; Nielsen EE; Feinberg J; Siddiqui F; Jørgensen CK; Barot E; Nielsen N; Bentzer P; Veroniki AA; Thabane L; Bu F; Klingenberg S; Gluud C; Jakobsen JC
    PLoS Med; 2020 Sep; 17(9):e1003293. PubMed ID: 32941437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review.
    Kaye AG; Siegel R
    PeerJ; 2020; 8():e10322. PubMed ID: 33194450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avoidance versus use of neuromuscular blocking agents for improving conditions during tracheal intubation or direct laryngoscopy in adults and adolescents.
    Lundstrøm LH; Duez CH; Nørskov AK; Rosenstock CV; Thomsen JL; Møller AM; Strande S; Wetterslev J
    Cochrane Database Syst Rev; 2017 May; 5(5):CD009237. PubMed ID: 28513831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study.
    Moreno-Pérez O; Andres M; Leon-Ramirez JM; Sánchez-Payá J; Rodríguez JC; Sánchez R; García-Sevila R; Boix V; Gil J; Merino E
    J Autoimmun; 2020 Nov; 114():102523. PubMed ID: 32690352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocilizumab in rheumatoid arthritis: a meta-analysis of efficacy and selected clinical conundrums.
    Navarro G; Taroumian S; Barroso N; Duan L; Furst D
    Semin Arthritis Rheum; 2014 Feb; 43(4):458-69. PubMed ID: 24262929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of high perioperative inspiratory oxygen fraction for adult surgical patients.
    Wetterslev J; Meyhoff CS; Jørgensen LN; Gluud C; Lindschou J; Rasmussen LS
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD008884. PubMed ID: 26110757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for prostate cancer.
    Ilic D; Neuberger MM; Djulbegovic M; Dahm P
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis.
    Zhong H; Wang Y; Zhang ZL; Liu YX; Le KJ; Cui M; Yu YT; Gu ZC; Gao Y; Lin HW
    Pharmacol Res; 2020 Jul; 157():104872. PubMed ID: 32360583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
    Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial.
    Naik NB; Puri GD; Kajal K; Mahajan V; Bhalla A; Kataria S; Singla K; Panigrahi P; Singh A; Lazar M; Chander A; Ganesh V; Hazarika A; Suri V; Goyal MK; Pandey VK; Kaloria N; Samra T; Saini K; Soni SL
    Cureus; 2021 Dec; 13(12):e20353. PubMed ID: 35036193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab for severe COVID-19: a systematic review and meta-analysis.
    Lan SH; Lai CC; Huang HT; Chang SP; Lu LC; Hsueh PR
    Int J Antimicrob Agents; 2020 Sep; 56(3):106103. PubMed ID: 32712333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.